Ixazomib is a kind of medication called a proteasome inhibitor that interferes with the growth of cancer cells by blocking some of the enzymes needed for cell growth. Ixazomib is used in the treatment of multiple myeloma.
| SparkCures ID | 36 |
|---|---|
| Developed By | Takeda Oncology |
| Brand Name | Ninlaro® |
| Generic Name | Ixazomib |
| Additional Names | MLN9708 |
| Treatment Classifications |
View all active clinical trials around the US.
The following is a listing of clinical trials for patients with multiple myeloma who have been newly diagnosed or have not yet received treatment.
The following is a listing of clinical trials for patients with multiple myeloma who have received one to two prior lines of therapy.
The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.